MYCN and neuroblastoma: On the other hand, genetically engineered mouse models are often developed under the control of a specific oncogenic driver (MYCN, ALK) and hence do not capture the genetic diversity of human NB, which has many oncogenic drivers, including copy number alterations, chromosomal imbalances and TERT rearrangements [9].